V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210038448 | 210034793 | 0.93 | 41.2 | Curative (C) | 2016-01-17 | 2016-01-31 | Methotrexate intrathecal | N | null | 210010330 | METHOTREXATE INTRATHECAL |
| 210038449 | 210006534 | 1.71 | 95.7 | Curative (C) | 2017-02-25 | 2017-10-19 | Methotrexate intrathecal | N | null | 210010379 | METHOTREXATE INTRATHECAL |
| 210038450 | 210006542 | 0 | 76 | Disease modification (D) | 2017-07-27 | 2018-01-04 | Methotrexate intrathecal | N | N | 210010396 | METHOTREXATE INTRATHECAL |
| 210038451 | 210025729 | null | 11.1 | Curative (C) | 2018-08-09 | 2018-10-11 | Methotrexate intrathecal | 1 | N | 210010402 | METHOTREXATE INTRATHECAL |
| 210038453 | 210030289 | 0 | 17.2 | Disease modification (D) | 2018-02-26 | 2018-04-12 | Methotrexate intrathecal | N | N | 210010482 | METHOTREXATE INTRATHECAL |
| 210038455 | 210006613 | 0.9 | 14.1 | Curative (C) | 2015-08-29 | 2015-09-05 | Methotrexate Intrathecal (any age) | Y | null | 210010604 | METHOTREXATE INTRATHECAL |
| 210038456 | 210006617 | 0 | 84.4 | Curative (C) | 2016-02-06 | 2016-05-29 | UKALL14- Ph 1 Induction | Y | N | 210010610 | UKALL2014 |
| 210038457 | 210006648 | null | 83 | Curative (C) | 2016-11-12 | 2017-03-17 | UKALL14- Intens/CNS Proph | Y | N | 210010708 | UKALL2014 |
| 210038458 | 210006674 | 1.87 | 79.9 | Curative (C) | 2017-10-04 | 2018-02-01 | UKALL14- Ph 2 Induction + Imatinib | N | N | 210010778 | UKALL2014 |
| 210038459 | 210006687 | null | 84 | Curative (C) | 2017-08-20 | 2017-09-09 | UKALL14- Cons Cycle 1 | N | N | 210010787 | UKALL2014 |
| 210038460 | 210006694 | 1.69 | 79 | Curative (C) | 2017-08-17 | 2017-08-28 | UKALL14- Maintenance | Y | N | 210010803 | UKALL2014 |
| 210038461 | 210006699 | null | 63 | Palliative (P) | 2017-09-02 | 2018-03-04 | UKALL14- Intens/CNS Proph | Y | N | 210010804 | UKALL2014 |
| 210038462 | 210006722 | 1.81 | 101 | Curative (C) | 2014-03-15 | 2014-11-21 | UKALL14- Intens/CNS Proph | 01 | null | 210010917 | UKALL2014 |
| 210038463 | 210006731 | 1.76 | 86.3 | Curative (C) | 2017-03-01 | 2017-04-04 | UKALL14- Maintenance | Y | N | 210010923 | UKALL2014 |
| 210038464 | 210025836 | 1.69 | 103 | Curative (C) | 2016-03-21 | 2016-10-16 | UKALL14- Cons Cycle 3 | Y | N | 210010965 | UKALL2014 |
| 210038465 | 210018616 | 1.61 | 91.8 | Curative (C) | 2015-05-21 | 2015-09-22 | UKALL 14 TRIAL | Y | N | 210010967 | UKALL2014 |
| 210038466 | 210006755 | 1.68 | 68.7 | Curative (C) | 2014-10-23 | 2014-10-23 | UKALL14- Intens/CNS Proph +Imatinib | 02 | N | 210010969 | UKALL2014 |
| 210038467 | 210006763 | 0 | 25.6 | Curative (C) | 2018-04-13 | 2019-01-08 | CNS Ependymoma II Cisplatin | N | N | 210010978 | NOT MATCHED |
| 210038468 | 210006777 | 0 | 56 | Curative (C) | 2019-03-30 | 2019-03-30 | CNS PNET 5 Medbl L/StRsk Mnt A Cis | 1 | N | 210010999 | NOT MATCHED |
| 210038469 | 210018643 | null | 34.7 | Palliative (P) | 2013-05-22 | 2014-01-15 | CNS Infant MBL HDMTX | Y | N | 210011043 | NOT MATCHED |
| 210038470 | 210006811 | 1.42 | 12 | Curative (C) | 2016-04-23 | 2016-07-24 | CNS PNET 5 Medbl L/StRsk Mnt A Carb | 2 | N | 210011068 | NOT MATCHED |
| 210038471 | 210006818 | null | 15.25 | Curative (C) | 2018-07-10 | 2018-11-14 | CNS PNET 5 Medbl L/StRsk Mnt A Carb | N | N | 210011090 | NOT MATCHED |
| 210038472 | 210033074 | null | 30.6 | Curative (C) | 2017-12-16 | 2018-04-07 | CNS Headstart II A Ind 1,2,3 int | N | N | 210011203 | NOT MATCHED |
| 210038473 | 210006862 | 0 | 66.4 | Curative (C) | 2018-05-22 | 2018-07-30 | ALL Int GdeC AugBFMCon PhII pt2PAsp | 02 | null | 210011220 | NOT MATCHED |
| 210038474 | 210018707 | 1.78 | 40 | Curative (C) | 2014-07-26 | 2015-02-17 | null | N | N | 210011282 | NOT MATCHED |
| 210038475 | 210006905 | null | 16.3 | Curative (C) | 2018-02-18 | 2018-04-29 | CNS Ependy II Vinc/Cyclophos | N | N | 210011405 | NOT MATCHED |
| 210038476 | 210018737 | null | 42.8 | Curative (C) | 2018-09-22 | 2018-09-26 | CHOP + Interferon alfa + + ZIDOVUDINE | N | N | 210011458 | NOT MATCHED |
| 210038477 | 210006934 | null | 50 | Curative (C) | 2018-03-16 | 2018-04-27 | CNS Medbl Std Risk Maint Carbo | Y | N | 210011483 | NOT MATCHED |
| 210038478 | 210025972 | null | 9.2 | Palliative (P) | 2018-02-27 | 2018-04-03 | null | 02 | N | 210011644 | NOT MATCHED |
| 210038479 | 210025976 | 1.57 | 62 | Palliative (P) | 2015-05-11 | 2015-05-15 | PCV | N | N | 210011690 | PCV |
| 210038480 | 210033099 | null | null | Curative (C) | 2017-07-16 | 2017-07-16 | PCV | N | N | 210011798 | PCV |
| 210038481 | 210007027 | 1.72 | 100 | Disease modification (D) | 2019-06-04 | 2019-07-06 | Temozolomide + RT | N | N | 210011965 | TEMOZOLOMIDE + RT |
| 210038482 | 210018823 | 1.72 | null | Curative (C) | 2016-01-16 | 2016-02-16 | Temozolomide + RT | N | Y | 210012048 | TEMOZOLOMIDE + RT |
| 210038484 | 210007091 | null | 71.7 | Disease modification (D) | 2015-11-28 | 2015-12-17 | IBRUTINIB | N | N | 210012198 | IBRUTINIB |
| 210038485 | 210007109 | 1.73 | 71.95 | Curative (C) | 2015-08-31 | 2018-12-05 | IBRUTINIB | N | N | 210012274 | IBRUTINIB |
| 210038486 | 210007114 | 1.8 | 47 | Curative (C) | 2015-09-28 | 2015-09-28 | IBRUTINIB | N | N | 210012295 | IBRUTINIB |
| 210038488 | 210007176 | 1.69 | null | Palliative (P) | 2018-11-06 | 2018-11-07 | Lomustine | N | N | 210012572 | LOMUSTINE |
| 210038490 | 210007228 | 1.7 | 75.3 | Curative (C) | 2017-06-06 | 2017-09-17 | BENDAMUSTINE + RITUXIMAB | N | N | 210012772 | BENDAMUSTINE + RITUXIMAB |
| 210038491 | 210007246 | 1.52 | 98.7 | Curative (C) | null | 2017-04-01 | VINCRISTINE | N | N | 210012870 | VINCRISTINE |
| 210038492 | 210007264 | 1.73 | 95.8 | Curative (C) | 2014-07-22 | 2014-08-20 | METHOTREXATE | N | N | 210012887 | METHOTREXATE |
| 210038493 | 210007339 | 0 | 67.1 | Curative (C) | 2016-10-07 | 2017-09-21 | IMATINIB | N | N | 210013032 | IMATINIB |
| 210038495 | 210007594 | 0 | 62.5 | Palliative (P) | 2019-11-28 | 2019-11-28 | METHOTREXATE | N | N | 210013640 | METHOTREXATE |
| 210038496 | 210007658 | 1.59 | 59.4 | Curative (C) | 2019-09-11 | 2019-09-11 | Imatinib 400mg | N | Y | 210013754 | IMATINIB |
| 210038497 | 210019108 | 1.8 | 92.5 | Curative (C) | 2018-03-10 | 2018-09-16 | Imatinib 400mg | N | N | 210013874 | IMATINIB |
| 210038498 | 210007729 | 1.7 | 79 | Curative (C) | 2013-02-25 | 2014-12-08 | Alemtuzumab | Y | N | 210013914 | ALEMTUZUMAB |
| 210038499 | 210007749 | null | 60.3 | Curative (C) | 2016-05-26 | 2016-11-26 | ALL Int Gde A/B DInt PhIV pt1 PAsp | N | N | 210013944 | ALL INTENSIFICATION |
| 210038500 | 210007919 | null | 73.4 | Curative (C) | 2014-07-29 | 2015-02-22 | ALL Int Guide A/B/C Maint Ph V | N | N | 210014311 | ALL INTERIM GUIDELINES |
| 210038501 | 210007981 | 1.67 | 55 | Curative (C) | 2014-10-24 | 2016-05-21 | ALL Int Gde A/B DInt PhIV pt1 PAsp | 2 | null | 210014466 | ALL INTENSIFICATION |
| 210038502 | 210008002 | 0 | 72.5 | Curative (C) | 2018-12-27 | 2019-01-05 | Carboplatin AUC 2 - 5 | N | N | 210014497 | CARBOPLATIN |
| 210038503 | 210019220 | null | 87.7 | Neo-adjuvant (N) | 2019-09-13 | 2020-07-07 | FLAG + Idarubicin | 99 | null | 210014561 | FLAG + IDARUBICIN |